Last Updated On 1/8/2026 12:53:20 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| Company: START |
| Recipient: You |
| Company: HM Hospitales Group |
| Recipient: You |
|
| Leadership |
| Company: START |
| Recipient: You |
| Company: PharmaMar |
| Recipient: You |
| Company: EORTC |
| Recipient: You |
| Company: Sanofi |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: CHUV |
| Recipient: You |
| Company: Oncomatryx |
| Recipient: You |
| Company: Shionogi |
| Recipient: You |
|
| Stock and Other Ownership Interests |
| Company: START |
| Recipient: You |
| Company: Oncoart Associated |
| Recipient: You |
| Company: HM Hospitales |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Janssen-Cilag |
| Recipient: You |
| Company: Roche/Genentech |
| Recipient: You |
| Company: TargImmune Therapeutics |
| Recipient: You |
| Company: Servier |
| Recipient: You |
| Company: Anaveon |
| Recipient: You |
| Company: AstraZeneca/MedImmune |
| Recipient: You |
| Company: Chugai Pharma |
| Recipient: You |
| Company: MonTa |
| Recipient: You |
| Company: Ellipses Pharma |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
| Company: Medsir |
| Recipient: You |
| Company: Weber Spain |
| Recipient: You |
| Company: Kivu |
| Recipient: You |
| Company: Grey Wolf Therapeutics |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Column Group |
| Recipient: You |
| Company: Aromics |
| Recipient: You |
| Company: Debiopharm Group |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: START |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: President and Founder of Foundation INTHEOS (Investigational Therapeutics in Oncological Sciences) |
| Recipient: You |
| Company: Non for profit Foundation PharmaMar |
| Recipient: You |
| Company: Non-for-profit CRIS Cancer Foundation |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|